Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_274590824

PhRMA launches lawsuit against the state of California over anti-price hike bill

December 11, 2017
Sales and Marketing Drug pricing, PhRMA, california, pharma, price hikes

The state of California has become the target of legal action after the lobbying group Pharmaceutical Research and Manufacturers of …

News
nhs_parliament_2_4

NHS trust boss of major hospital hands in fiery resignation notice

December 11, 2017
Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

Bob Kerslake, now former chair of King’s College hospital, London, has handed in his resignation, citing the lack of long-term …

News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

December 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, most read news, pharma, pharmaceutical, top ten

Despite us nearing the end of the year, the news has not been slowing down at all. Headlines across Europe …

News
roche_close

Roche Tecentriq combo effective, but is it enough?

December 8, 2017
Medical Communications, Research and Development Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

When Roche announced that its combination treatment of Tecentriq, alongside its own drug Avastin and chemotherapy, successfully extended progression-free survival …

News
gilead-sciences

Gilead makes $567m strategic acquisition for next-gen CAR-T

December 8, 2017
Medical Communications, Sales and Marketing CAR-T, Cell Design Labs, Gilead, Kite, biotech, drugs, pharma, pharmaceutical

It’s only four months since Gilead completed its buy-out of Kite Pharma for $11.9 billion, but it’s already moving quickly …

News
philippines-1195394_960_720

Philippines ups pressure on Sanofi over dengue vaccine

December 8, 2017
Medical Communications Sanofi, biotech, drugs, pharma, pharmaceutical

Since Sanofi released further data from a six-year study which showed that the risk of a severe dengue reaction is …

News
upwards_graph

Sage Therapeutics stock pops on depression P2 results

December 8, 2017
Medical Communications, Research and Development Sage Therapeutics, biotech, drugs, pharma, pharmaceutical

Sage Therapeutics’ stock rocketed after it announced that Phase 2 results for its treatment for major depressive disorder (MDD) were …

News
james-levine-11206608

Fondation Ipsen announces Dr James Levine as new President

December 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Fondation Ipsen has announced its appointment of Dr James A Levine as its new President. The organisation was set up …

Appointment

FDA access programmes shaved up to a year off drug approval times, new study shows

December 7, 2017
Research and Development, Sales and Marketing FDA, market access, pharma

A research letter published this week has suggested that the FDA initiatives to accelerate drug approvals in the US could …

News
dna-163466

Getting precision treatments over the line will be a team effort, not an individual bolt for glory

December 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Prostate Cancer UK, biotech, drugs, pharma, pharmaceutical, prostate cancer

We’ve finally reached the starter’s block when it comes to precision medicine approaches to prostate cancer, but Dr Matthew Hobbs, …

Feature
novartislr

Novartis Kisqali improves PFS in younger women

December 7, 2017
Research and Development Kisqali, Novartis, biotech, drugs, pharma, pharmaceutical

A Phase 3 trial looking at the use of Kisqali (ribociclib) to treat premenopausal or perimenopausal women with hormone-receptor positive, …

News
roche__tree

Roche’s haemophilia A drug shows meaningful bleed control in P3

December 7, 2017
Research and Development Roche, haemophilia, pharma

Roche has unveiled new Phase 3 data for its haemophilia A treatment Helimbra (emicizumab) in patients over 12 years of …

News

Old anti-drinking drug shows potential as cancer treatment

December 7, 2017
Research and Development Cancer, biotech, drugs, oncology, pharma, pharmaceutical

Disulfiram has been known as an anti-drinking compound for nearly seven decades. Initially, the compound was used in the vulcanisation …

News
Drug R&D

Clinical trial transparency research reveals progress, but more to be done

December 7, 2017
Medical Communications biotech, clinical trials, drugs, pharma, pharmaceutical

Bioethics international, a non-profit organisation, has published its second annual index ranking pharma companies by the transparency of data from …

News
shutterstock

Galectin Therapeutics’ share value plummets by half after NASH drug failure

December 6, 2017
Research and Development Galectin Therapeutics, nash, pharma, trial failure

Galectin Therapeutics has seen its share value almost halve after its revealed that GR-MD-02, its experimental treatment for non-alcoholic steatohepatitis …

News
news_accc

Two big pharma companies accused of false marketing

December 6, 2017
Research and Development, Sales and Marketing GSK, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis and GSK have been taken to court by the Australian Competition and Consumer Commission (ACCC) over allegations of falsely …

News
gsk_wall

GSK commits to multi-million investment in UK life sciences sector deal

December 6, 2017
Research and Development, Sales and Marketing GSK, biotech, drugs, pharma, pharmaceutical

In the latest boost to the UK’s life sciences strategy, GSK has committed £40 million to its work identifying new …

News
novartis_window

Novartis nets first acute myeloid leukaemia approval in Canada, but NICE says no

December 6, 2017
Research and Development, Sales and Marketing Canada, NICE, Novartis, Rydapt, UK, acute myeloid leukaemia, leukaemia, pharma

Novartis is celebrating the news that its drug Rydapt (midostaurin) has been awarded marketing approval in Canada for the treatment …

News
aaeaaqaaaaaaaadzaaaajda2mmvkoduzltaxndctngywns1iztq3lwm3mtg3mzk0njnkyw

Veeva launches upgrade to Veeva CRM Engage

December 6, 2017
Medical Communications Zinc systems, biotech, drugs, pharma, pharmaceutical, veeva

Veeva took the opportunity at its European Commercial & Medical Summit to reveal the latest upgrade to its Veeva CRM …

News
diabetes-2424105_960_720

Study reveals diet able to reverse diabetes in half of patients

December 6, 2017
Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

Building on their previous research emerging from Professor Roy Taylor’s work at Newcastle University, a study has found that 45.6% …

News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026